India, Sept. 17 -- Shares of Aethlon Medical (AEMD) is currently surging nearly 385% after the company announced an all-stock merger with North Immunology. The company also announced an oversubscribed $180 million private placement to advance North's antibody drug candidate NOR-101.
The stock is currently trading at $6.94, up $5.51 or 384.97%, on the Nasdaq. It opened at $8.54 after closing the previous session at $1.43. The stock has traded between $1.41 and $41.50 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....